Lafontan, Max
Institut des Maladies Métaboliques et Cardiovasculaires,
France
2025 Rank: 150664
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 1109 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 150664 | 174057 |
| Total Cites | 335 | 339 |
| H-index | 8 | 8 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 18 | 18 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 86 | 87 |
| Number of Single+First+Last Authored Papers | 147 | 147 |
| Total Cites to Single+First+Last Authored Papers | 126 | 128 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 279 | 282 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.20 |
| Self-Citation Percentage |
1.18%
|
|
Lafontan, Max
Inserm,
France
2024 Rank: 75493
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 427 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75493 | 88481 |
| Total Cites | 395 | 403 |
| H-index | 9 | 9 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 31 | 31 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 103 | 103 |
| Number of Single+First+Last Authored Papers | 147 | 147 |
| Total Cites to Single+First+Last Authored Papers | 153 | 153 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 330 | 334 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.21 |
| Self-Citation Percentage |
1.99%
|
|
Lafontan, Max
Hôpital Rangueil,
France
2023 Rank: 67568
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 422 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67568 | 78672 |
| Total Cites | 465 | 483 |
| H-index | 11 | 11 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 28 | 28 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 118 | 119 |
| Number of Single+First+Last Authored Papers | 148 | 148 |
| Total Cites to Single+First+Last Authored Papers | 162 | 163 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 400 | 409 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
3.73%
|
|
Lafontan, Max
Hôpital Rangueil,
France
2022 Rank: 62820
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 373 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62820 | 72929 |
| Total Cites | 471 | 484 |
| H-index | 11 | 11 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 29 | 29 |
| Total Cites to Single Authored Papers | 29 | 29 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 124 | 127 |
| Number of Single+First+Last Authored Papers | 148 | 148 |
| Total Cites to Single+First+Last Authored Papers | 174 | 179 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 388 | 394 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.23 |
| Self-Citation Percentage |
2.69%
|
|
Lafontan, Max
Universite Paul Sabatier Toulouse III,
France
2021 Rank: 44338
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 788 out of 81805 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44338 | 51374 |
| Total Cites | 780 | 815 |
| H-index | 13 | 13 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 51 | 51 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 206 | 209 |
| Number of Single+First+Last Authored Papers | 147 | 147 |
| Total Cites to Single+First+Last Authored Papers | 303 | 309 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 624 | 635 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.28 |
| Self-Citation Percentage |
4.29%
|
|
Lafontan, Max
Universite Paul Sabatier Toulouse III,
France
2020 Rank: 33589
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 640 out of 69094 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33589 | 38722 |
| Total Cites | 642 | 665 |
| H-index | 13 | 13 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 49 | 49 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 182 | 183 |
| Number of Single+First+Last Authored Papers | 147 | 147 |
| Total Cites to Single+First+Last Authored Papers | 248 | 254 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 506 | 518 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.28 |
| Self-Citation Percentage |
3.46%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.